PERSPECTIVE THERAPEUTICS PRESENTS ENCOURAGING INCREMENTAL DATA AND ANALYSES FROM PHASE 1/2A TRIAL OF [212PB]BAMZIREOTIDE NAVOXETAN (VMT-Α-NET) IN ADVANCED SSTR2 EXPRESSING NETS

Reuters · 2d ago

Please log in to view news